My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 91

    1.

    Leishmania amastigotes as targets for drug screening.

    Monte-Alegre A, Ouaissi A, Sereno D.

    Kinetoplastid Biol Dis. 2006 Oct 23;5:6.PMID: 17059597 [PubMed]Related articlesFree article

    2.

    Advances and perspectives in Leishmania cell based drug-screening procedures.

    Sereno D, Cordeiro da Silva A, Mathieu-Daude F, Ouaissi A.

    Parasitol Int. 2007 Mar;56(1):3-7. Epub 2006 Oct 31. Review.PMID: 17079188 [PubMed - indexed for MEDLINE]Related articles

    3.

    Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening.

    Singh N, Gupta R, Jaiswal AK, Sundar S, Dube A.

    J Antimicrob Chemother. 2009 Aug;64(2):370-4. Epub 2009 Jun 12.PMID: 19525291 [PubMed - indexed for MEDLINE]Related articles

    4.

    Rapid fluorescent assay for screening drugs on Leishmania amastigotes.

    Shimony O, Jaffe CL.

    J Microbiol Methods. 2008 Oct;75(2):196-200. Epub 2008 Jun 5.PMID: 18573286 [PubMed - indexed for MEDLINE]Related articles

    5.

    Transgenic, fluorescent Leishmania mexicana allow direct analysis of the proteome of intracellular amastigotes.

    Paape D, Lippuner C, Schmid M, Ackermann R, Barrios-Llerena ME, Zimny-Arndt U, Brinkmann V, Arndt B, Pleissner KP, Jungblut PR, Aebischer T.

    Mol Cell Proteomics. 2008 Sep;7(9):1688-701. Epub 2008 May 12.PMID: 18474515 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Visualisation and quantitative analysis of the rodent malaria liver stage by real time imaging.

    Ploemen IH, Prudêncio M, Douradinha BG, Ramesar J, Fonager J, van Gemert GJ, Luty AJ, Hermsen CC, Sauerwein RW, Baptista FG, Mota MM, Waters AP, Que I, Lowik CW, Khan SM, Janse CJ, Franke-Fayard BM.

    PLoS One. 2009 Nov 18;4(11):e7881.PMID: 19924309 [PubMed - in process]Related articlesFree article

    7.

    Antiparasitic chemotherapy: tinkering with the purine salvage pathway.

    Datta AK, Datta R, Sen B.

    Adv Exp Med Biol. 2008;625:116-32. Review.PMID: 18365663 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Development of antituberculous drugs: current status and future prospects]

    Tomioka H, Namba K.

    Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese. PMID: 17240921 [PubMed - indexed for MEDLINE]Related articles

    9.

    Leishmania infantum: antiproliferative effect of recombinant plant cystatins on promastigotes and intracellular amastigotes estimated by direct counting and real-time PCR.

    Ordóñez-Gutiérrez L, Martínez M, Rubio-Somoza I, Díaz I, Mendez S, Alunda JM.

    Exp Parasitol. 2009 Dec;123(4):341-6. Epub 2009 Aug 31.PMID: 19723520 [PubMed - indexed for MEDLINE]Related articles

    10.

    A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen.

    Deb C, Lee CM, Dubey VS, Daniel J, Abomoelak B, Sirakova TD, Pawar S, Rogers L, Kolattukudy PE.

    PLoS One. 2009 Jun 29;4(6):e6077.PMID: 19562030 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes.

    Miguel DC, Yokoyama-Yasunaka JK, Andreoli WK, Mortara RA, Uliana SR.

    J Antimicrob Chemother. 2007 Sep;60(3):526-34. Epub 2007 Jun 21.PMID: 17584801 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Unveiling pathways used by Leishmania amazonensis amastigotes to subvert macrophage function.

    Osorio y Fortéa J, Prina E, de La Llave E, Lecoeur H, Lang T, Milon G.

    Immunol Rev. 2007 Oct;219:66-74. Review.PMID: 17850482 [PubMed - indexed for MEDLINE]Related articles

    13.

    Whole-genome comparative RNA expression profiling of axenic and intracellular amastigote forms of Leishmania infantum.

    Rochette A, Raymond F, Corbeil J, Ouellette M, Papadopoulou B.

    Mol Biochem Parasitol. 2009 May;165(1):32-47. Epub 2009 Jan 15.PMID: 19393160 [PubMed - indexed for MEDLINE]Related articles

    14.

    Searching the Tritryp genomes for drug targets.

    Myler PJ.

    Adv Exp Med Biol. 2008;625:133-40. Review.PMID: 18365664 [PubMed - indexed for MEDLINE]Related articles

    15.

    Simultaneous gene expression profiling in human macrophages infected with Leishmania major parasites using SAGE.

    Guerfali FZ, Laouini D, Guizani-Tabbane L, Ottones F, Ben-Aissa K, Benkahla A, Manchon L, Piquemal D, Smandi S, Mghirbi O, Commes T, Marti J, Dellagi K.

    BMC Genomics. 2008 May 21;9:238.PMID: 18495030 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    High-throughput screening of amastigotes of Leishmania donovani clinical isolates against drugs using a colorimetric beta-lactamase assay.

    Mandal S, Maharjan M, Ganguly S, Chatterjee M, Singh S, Buckner FS, Madhubala R.

    Indian J Exp Biol. 2009 Jun;47(6):475-9.PMID: 19634714 [PubMed - indexed for MEDLINE]Related articles

    17.

    Selection of targets for drug development against protozoan parasites.

    de Azevedo WF Jr, Soares MB.

    Curr Drug Targets. 2009 Mar;10(3):193-201. Review.PMID: 19275556 [PubMed - indexed for MEDLINE]Related articles

    18.

    Real-time in vivo green fluorescent protein imaging of a murine leishmaniasis model as a new tool for Leishmania vaccine and drug discovery.

    Mehta SR, Huang R, Yang M, Zhang XQ, Kolli B, Chang KP, Hoffman RM, Goto Y, Badaro R, Schooley RT.

    Clin Vaccine Immunol. 2008 Dec;15(12):1764-70. Epub 2008 Oct 22.PMID: 18945882 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The Leishmania-macrophage interaction: a metabolic perspective.

    Naderer T, McConville MJ.

    Cell Microbiol. 2008 Feb;10(2):301-8. Epub 2007 Dec 9. Review.PMID: 18070117 [PubMed - indexed for MEDLINE]Related articles

    20.

    Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.

    Yang KC, Liao CS, Chiu YH, Yen AM, Chen TH.

    J Med Screen. 2006;13 Suppl 1:S8-13.PMID: 17227635 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk